You are here: Industry Insights > antibody

News List

Biomunex, Onward Ink Strategic Antibody Development Pact contractpharma
February 18, 2021
Exclusive worldwide license and development agreement will leverage Biomunex' next gen bi- and multi-specific antibody platform in hematological malignancies.
How SARS-CoV-2 mutates to escape antibody binding worldpharmanews
February 08, 2021
In a recurring pattern of evolution, SARS-CoV-2 evades immune responses by selectively deleting small bits of its genetic sequence, according to new research from the University of Pittsburgh School of Medicine.
OSE Immunotherapeutics Expands Collaboration with MAbSilico americanpharmaceuticalreview
February 05, 2021
OSE Immunotherapeutics announced a new collaboration agreement with MAbSilico, a deep technology TechBio located in Tours, France, to use artificial intelligence (AI)-based software for therapeutic monoclonal antibody drug development.
Lilly, US health systems partner to set up Covid-19 antibody infusion centres pharmaceutical-technology
February 03, 2021
Eli Lilly and Company and local health systems have partnered to establish dedicated infusion centre locations in the US to offer Hoosiers with access to vital Covid-19 treatments.
BeiGene announces collaboration with Novartis to develop and commercialize anti-PD-1 antibody Tislelizumab pharmaceutical-business-review
January 14, 2021
BeiGene announced a collaboration and license agreement with Novartis Pharma AG to develop, manufacture and commercialize BeiGene’s anti-PD-1 antibody tislelizumab in the United States, Canada, Mexico, member countries of the European Union ...
Study finds antibodies target different parts of SARS-CoV-2 in severe COVID-19 cases expresspharma
December 28, 2020
People with severe COVID-19 have lower levels of antibodies targeting the spike protein used by the virus to enter human cells than those targeting proteins of the inner shell of the SARS-CoV-2 virus.
Fusion Antibodies, Queen’s University Belfast Receives Grant for COVID-19 Antibody Research americanpharmaceuticalreview
December 24, 2020
Fusion Antibodies and Queen’s University Belfast have been awarded a £453,000 grant from Invest Northern Ireland to further expand their COVID-19 targeted research and development efforts.
Phase I clinical trial outcome shows Covaxin generates antibody, T-cell memory response expresspharma
December 24, 2020
Bharat Biotech’s COVID-19 vaccine Covaxin has shown positive long term antibody and T cell memory response in Phase I clinical trial.
Abbott receives CE mark for COVID-19 IgG quantitative antibody blood test europeanpharmaceuticalreview
December 17, 2020
The new quantitative SARS-CoV-2 IgG lab-based serology test developed by Abbott has been given the CE mark.
Harbour BioMed and Utrecht University Announce License Agreement with AbbVie and Initiation of COVID-19 Antibody Clinical Trials prnasia
December 15, 2020
Harbour BioMed (HBM), and Utrecht University (UU) today announced that they licensed to AbbVie their fully human, SARS-CoV-2 neutralizing antibody, 47D11 and program, for the prevention and treatment of COVID-19 and related coronaviruses, and that ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page